2026 NPPES data Hospitalist Physician NPI 1780765461 M.D.
Verify on CMS →

SAMER EL-CHEMEITELLI, M.D.

Hospitalist Physician in HARRIMAN, Tennessee. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 319 beneficiaries · Hospitalist Physician avg: 888
Generic prescribing
34%
generic claims · 66% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$16.24
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SAMER EL-CHEMEITELLI, M.D. is a Hospitalist Physician ([object Object]) practicing in HARRIMAN, Tennessee with a Medicare Part D prescribing footprint of 2K claims across 319 beneficiaries — 66% brand-name prescribing . Industry payments of $16.24 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SAMER EL-CHEMEITELLI, M.D. filed 2,210 Medicare Part D claims in 2023 across HARRIMAN, Tennessee. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SAMER EL-CHEMEITELLI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SAMER EL-CHEMEITELLI, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 10/18/2006

NPI 1780765461

Primary specialty

Hospitalist Physician

Mid-sized

16,825 US NPIs in this specialty

Medicare Part D claims

2,210 149% vs specialty avg

2023 prescription claims

Specialty avg: 888

Specialty distribution in Tennessee

How Hospitalist Physician compares to other specialties among Tennessee providers

Tennessee providers

Hospitalist Physician share within Tennessee

1. Hospitalist Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hospitalist Physician share within Tennessee

Specialty board-certification context

Estimated specialty board-certified rate — Hospitalist Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hospitalist Physician ABMS/AOA estimate

Est. board-certified rate (Hospitalist Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hospitalist Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SAMER EL-CHEMEITELLI, M.D. is a Hospitalist Physician provider practicing in HARRIMAN, Tennessee, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1780765461. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SAMER EL-CHEMEITELLI, M.D. appears in the CMS NPPES registry as a Hospitalist Physician provider holding M.D. credentials at 525 DEVONIA ST STE A, HARRIMAN, TN, 37748, with a listed phone of (865) 882-0046. NPI 1780765461 was issued on 10/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what EL-CHEMEITELLI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,210 prescription claims written by this provider, covering 319 Medicare beneficiaries and totaling roughly $995K in drug spend, split 66% brand-name and 34% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hospitalist Physician is a mid-sized specialty nationwide, with 16,825 enrolled providers across 54 states and an average of 888 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

525 DEVONIA ST STE A
HARRIMAN, TN 37748

Provider Details

NPI 1780765461
Specialty Hospitalist Physician
Credentials M.D.
Gender Male
NPI Issued 10/18/2006

Hospital and facility affiliations

Facilities where SAMER EL-CHEMEITELLI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COVENANT MEDICAL GROUP INC
LOUDON, TN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAMER EL-CHEMEITELLI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$16

Largest payer

Insmed, Inc.

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

SAMER EL-CHEMEITELLI, M.D. — brand share 66.0%
Specialty average (est.)

66% brand-name claims vs 34% generic, on 2,210 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,210
Total Claims
$995K
Total Drug Cost
319
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,812
Total Day Supply
78,003
Brand vs Generic
66% brand / 34% generic
Brand Drug Cost
$890K
Generic Drug Cost
$104K
Antibiotic Claims
56

Patient Demographics

Average Patient Age
70.1 years
Avg HCC Risk Score
2.13
Gender Split
56% female / 44% male
Age Distribution
<65: 75, 65-74: 143, 75-84: 85, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
372
Symbicort
Budesonide/Formoterol Fumarate
348
Spiriva Respimat
Tiotropium Bromide
307
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
268
Prednisone
186
Montelukast Sodium
115
Breo Ellipta
Fluticasone/Vilanterol
74
Fluticasone Propionate
51
Spiriva Handihaler
Tiotropium Bromide
39
Incruse Ellipta
Umeclidinium Bromide
38

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hospitalist Physician Overview

How SAMER EL-CHEMEITELLI, M.D. fits within the Hospitalist Physician landscape nationally.

16,825
Hospitalist Physician Providers in US
54
States with Hospitalist Physician
888
Avg Claims per Provider

SAMER EL-CHEMEITELLI, M.D.'s 2,210 claims are above the specialty average of 888.

Nearby Hospitalist Physician Providers in Tennessee

Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as EL-CHEMEITELLI.

Compare Hospitalist Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SAMER EL-CHEMEITELLI, M.D.'s specialty?
SAMER EL-CHEMEITELLI, M.D. specializes in Hospitalist Physician and practices in HARRIMAN, Tennessee. Credentials: M.D..
How much does SAMER EL-CHEMEITELLI, M.D. prescribe under Medicare Part D?
In 2023, SAMER EL-CHEMEITELLI, M.D. wrote 2,210 Medicare Part D claims totaling $995K in drug costs for 319 beneficiaries.
Where is SAMER EL-CHEMEITELLI, M.D. located?
SAMER EL-CHEMEITELLI, M.D. is located at 525 DEVONIA ST STE A, HARRIMAN, TN, 37748. Phone: (865) 882-0046.
What is SAMER EL-CHEMEITELLI, M.D.'s NPI number?
SAMER EL-CHEMEITELLI, M.D.'s National Provider Identifier (NPI) is 1780765461, issued on 10/18/2006.
Does SAMER EL-CHEMEITELLI, M.D. prescribe more brand-name or generic drugs?
SAMER EL-CHEMEITELLI, M.D.'s prescribing is 66% brand-name and 34% generic drugs by claim count, with $890K in brand drug costs.
How many Hospitalist Physician providers are there in the US?
There are 16,825 Hospitalist Physician providers across 54 states in the US. The average Hospitalist Physician provider writes 888 Medicare Part D claims per year.
What drugs does SAMER EL-CHEMEITELLI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SAMER EL-CHEMEITELLI, M.D.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Symbicort, Spiriva Respimat. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SAMER EL-CHEMEITELLI, M.D. accept Medicare?
SAMER EL-CHEMEITELLI, M.D. appears in CMS Medicare data with 2,210 Part D claims and 319 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SAMER EL-CHEMEITELLI, M.D.'s credentials?
SAMER EL-CHEMEITELLI, M.D.'s NPI is 1780765461 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology